PolyPid Overview
- Year Founded
-
2008
- Status
-
Public
- Employees
-
75
- Stock Symbol
-
PYPD
- Share Price
-
$6.26
- (As of Friday Closing)
PolyPid General Information
Description
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
Contact Information
Website
www.polypid.comCorporate Office
- 18 Hasivim Street
- Post Office Box 7126
- Petah Tikva 4917002
- Israel
Corporate Office
- 18 Hasivim Street
- Post Office Box 7126
- Petah Tikva 4917002
- Israel
PolyPid Timeline
PolyPid Stock Performance
As of 13-Nov-2026, PolyPid’s stock price is $6.26. Its current market cap is $132M with 21.1M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $6.26 | $6.40 | $3.50 - $7.15 | $132M | 21.1M | 124K | -$1.35 |
PolyPid Financials Summary
As of 30-Sep-2026, PolyPid has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 102,052 | 57,743 | 31,463 | 7,972 |
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (32,349) | (26,290) | (20,904) | |
| Net Income | (29,804) | (34,169) | (29,022) | (23,865) |
| Total Assets | 40,120 | 22,307 | 25,220 | 15,372 |
| Total Debt | 1,257 | 2,796 | 9,617 | 11,779 |
PolyPid Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
PolyPid Comparisons
Industry
Financing
Details
PolyPid Competitors (3)
One of PolyPid’s 3 competitors is Pacira BioSciences, a Formerly VC-backed company based in Tampa, FL.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Pacira BioSciences | Formerly VC-backed | Tampa, FL | ||||
| Urogen Pharma | Formerly VC-backed | Princeton, NJ | ||||
| Heron Therapeutics | Formerly VC-backed | Cary, NC |
PolyPid Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
PolyPid Patents
PolyPid Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2021405274-A1 | Compositions and methods for the treatment of solid tumors | Pending | 21-Dec-2020 | ||
| CA-3197114-A1 | Compositions and methods for the treatment of solid tumors | Pending | 21-Dec-2020 | ||
| EP-4262783-A1 | Compositions and methods for the treatment of solid tumors | Pending | 21-Dec-2020 | ||
| US-20240050396-A1 | Compositions and methods for the treatment of solid tumors | Pending | 21-Dec-2020 | ||
| WO-2022137126-A1 | Compositions and methods for the treatment of solid tumors | Inactive | 21-Dec-2020 | A61K9/0019 |
PolyPid Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
PolyPid Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
PolyPid ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
PolyPid FAQs
-
When was PolyPid founded?
PolyPid was founded in 2008.
-
Where is PolyPid headquartered?
PolyPid is headquartered in Petah Tikva, Israel.
-
What is the size of PolyPid?
PolyPid has 75 total employees.
-
What industry is PolyPid in?
PolyPid’s primary industry is Drug Delivery.
-
Is PolyPid a private or public company?
PolyPid is a Public company.
-
What is PolyPid’s stock symbol?
The ticker symbol for PolyPid is PYPD.
-
What is the current stock price of PolyPid?
As of 13-Nov-2026 the stock price of PolyPid is $6.26.
-
What is the current market cap of PolyPid?
The current market capitalization of PolyPid is $132M.
-
Who are PolyPid’s competitors?
Pacira BioSciences, Urogen Pharma, and Heron Therapeutics are competitors of PolyPid.
-
What is PolyPid’s annual earnings per share (EPS)?
PolyPid’s EPS for 12 months was -$1.35.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
